State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Dingxi Road, Shanghai 200050, China.
J Biomater Appl. 2012 Feb;26(6):637-50. doi: 10.1177/0885328210383599. Epub 2010 Sep 28.
Pure Ca(5)(PO(4))(2)SiO(4) bioceramic was first prepared by a sol-gel method using triethyl phosphate, tetraethoxysilane, and calcium nitrate tetrahydrate as original materials. Simulated body fluid (SBF) immersion tests revealed that Ca(5)(PO(4))(2)SiO(4) samples had a greater in vitro apatite-forming ability than hydroxyapatite (HA). After soaking Ca(5)(PO(4))(2)SiO(4) samples in the SBF for 1 day, bone-like apatite precipitated on the surfaces and the apatite layer became thicker with increasing the soaking time. However, few bone-like apatites precipitated on the HA samples even after soaking in the SBF for 7 days. The good in vitro bioactivity of Ca(5)(PO(4))(2)SiO(4) samples was attributed to the silanol (Si-OH) groups and greater solubility of Ca(5)(PO(4))(2)SiO(4). In addition, hot-pressed Ca(5)(PO(4))(2)SiO(4) ceramic exhibited lower bending strength and elastic modulus than hot-pressed HA, since the former had a lower relative density than the latter. The results have shown that Ca(5)(PO(4))(2)SiO(4) is a potential candidate material for bone repair.
纯 Ca(5)(PO(4))(2)SiO(4) 生物陶瓷最初是通过溶胶-凝胶法用三乙膦酸酯、四乙氧基硅烷和硝酸钙四水合物作为原料制备的。模拟体液(SBF)浸泡试验表明,Ca(5)(PO(4))(2)SiO(4) 样品具有比羟基磷灰石(HA)更强的体外成磷灰石能力。将 Ca(5)(PO(4))(2)SiO(4) 样品浸泡在 SBF 中 1 天后,表面上会沉淀出类骨磷灰石,并且随着浸泡时间的增加,磷灰石层会变厚。然而,即使将 HA 样品浸泡在 SBF 中 7 天,也几乎没有类骨磷灰石沉淀。Ca(5)(PO(4))(2)SiO(4) 样品具有良好的体外生物活性,这归因于硅醇(Si-OH)基团和 Ca(5)(PO(4))(2)SiO(4) 的更大溶解度。此外,热压 Ca(5)(PO(4))(2)SiO(4) 陶瓷的抗弯强度和弹性模量均低于热压 HA,因为前者的相对密度低于后者。结果表明,Ca(5)(PO(4))(2)SiO(4) 是一种潜在的骨修复候选材料。